TheCRE.com
CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Reg Week Archives
Data Access
Data Quality
Regulation by Litigation
Regulation by Information
Regulation by Appropriation
Special Projects
CRE Watch List
Emerging Regulatory Issues
Litigation
OMB Papers
Abstracts and Reviews
Guest Column
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Interactive Public Docket
Electronic Regulatory Reform
Consumer Response Service
Site Search

Enter keyword(s) to search TheCre.com:

®: CRE Regulatory Action of the Week

FDA Releases Draft Guidance on Mammography Quality Standards Act

The Food and Drug Administration (FDA) has announced the availability of the draft guidance entitled "Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #4." According to the FDA this document is intended to help facilities meet the Mammography Quality Standards Act of 1992's final regulations, which became effective April 28, 1999. The FDA also states that this draft guidance is neither final nor in effect at this time. Written comments concerning this draft guidance must be received by December 12, 2000.

Click to read notice in Federal Register:

CRE invites all interested parties to submit comments on these issues to CRE's Interactive Public Docket.

Please click below to submit comments regarding Draft Guidance on Mammography Quality Standards Act.

Draft Guidance on Mammography Quality Standards Act: Interactive Public Docket

View past ®:CRE Regulatory Action of the Week items